Search

everythinglearnresearchcommunity

for

Search:↓

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

p53 protein may help protect or kill neurons under stress.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

More research is needed to confirm the potential of various treatments, including Helichrysum plicatum, vitamins, bromelain, personalized medications, hydrogels, and bacteriophage therapy.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

PDCD4 is important for controlling skin cell growth and healing.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

PLD is an effective and safer alternative for treating breast cancer.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.